Internal Medicine, Hematology & Oncology · Cleveland, OH
NPI
1750677613
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
11100 Euclid Ave
Cleveland, OH, 44106
Phone (216) 864-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
381 services
Medicare patients, 2024
101
Average age 70
Drug cost, 2024
$5.2M
1,238 prescriptions
Company payments, 2025
$24K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Molly M Gallogly was code 99215 (office e&m - established), 206 times for 74 patients. In total Molly M Gallogly billed 381 services in 11 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 206 | 74 | $100.59 | $21K |
| 99233 Hospital E&M - Subsequent | Facility | 110 | 20 | $89.25 | $9,817 |
| 99214 Office E&M - Established | Facility | 26 | 21 | $53.26 | $1,385 |
By year: 2022 $33K for 387 services; 2023 $36K for 386 services; 2024 $35K for 381 services.
Medicare prescription drug claims, 2024
In 2024, the drug Molly M Gallogly prescribed most often to Medicare patients was Acyclovir, with 203 prescriptions and refills. In total Molly M Gallogly wrote 1,238 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 203 | 292 | 47 | $2,411 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 77 | 94 | 19 | $260 |
| Lenalidomide Generic | 53 | 53 | Under 11 | $719K |
| Venclexta Venetoclax | 47 | 47 | 11 | $352K |
| Ninlaro Ixazomib Citrate | 39 | 39 | Under 11 | $504K |
| Jakafi Ruxolitinib Phosphate | 36 | 36 | Under 11 | $468K |
| Gabapentin Generic | 34 | 42 | Under 11 | $782 |
| Brukinsa Zanubrutinib | 33 | 33 | Under 11 | $375K |
| Allopurinol Generic | 32 | 48 | 11 | $182 |
| Dexamethasone Generic | 31 | 32 | Under 11 | $174 |
| Pantoprazole Sodium Generic | 30 | 48 | Under 11 | $135 |
| Ondansetron Hcl Generic | 25 | 27 | 15 | $563 |
| Eliquis Apixaban | 25 | 31 | Under 11 | $16K |
| Hydroxyurea Generic | 21 | 30 | Under 11 | $237 |
| Posaconazole Generic | 19 | 19 | Under 11 | $13K |
Brand drugs: - claims; generic drugs: 903 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Molly M Gallogly $24K ($24K in general payments such as food, travel and fees) from 7 companies. The largest payer was Lilly USA, LLC with $14K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.